Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Predictive Oncology Q2 EPS $(0.22) Misses $(0.09) Estimate, Sales $2.682K Down From $67.255K YoY

Author: Benzinga Newsdesk | August 13, 2025 05:47pm
Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.09) by 144.44 percent. This is a 58.49 percent increase over losses of $(0.53) per share from the same period last year. The company reported $2.682 thousand in sales this quarter. This is a 96.01 percent decrease over sales of $67.255 thousand the same period last year.

Posted In: POAI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist